https://doi.org/10.3390/cancers15041173
S
Steffi Hartmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
139
Papers
1.5K
Citations
19
h-index
27
i10-index
Steffi Hartmann is an academic researcher from University of Rostock. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Breast Implant and Reconstruction. The author has an h-index of 19, co-authored 119 publications.
ORCID: 0000-0002-0145-1589Papers by this author
worksLocalization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)
2023 · Cancers · 72 citations
Accuracy of axillary ultrasound in preoperative nodal staging of breast cancer - size of metastases as limiting factor
2013 · SpringerPlus · 62 citations
https://doi.org/10.1186/2193-1801-2-350
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers
2022 · Journal of Cancer Research and Clinical Oncology · 42 citations
https://doi.org/10.1007/s00432-022-03938-x
SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
2016 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-016-2373-3
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer—a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
2025 · Breast Cancer Research and Treatment · 5 citations
https://doi.org/10.1007/s10549-025-07635-4
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
2025 · European Journal of Surgical Oncology · 4 citations
https://doi.org/10.1016/j.ejso.2025.110253
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat